Security | Threat Detection | Cyberattacks | DevSecOps | Compliance

Egnyte

5 Key Considerations When Working with a CMMC Partner

While regulations like Cybersecurity Maturity Model Certification (CMMC) 2.0 have expanded in size and scope in the past several years, my experience with CMMC actually dates back to early 2017. At the time, I was working with a client who was a contractor for the U.S. Department of Defense. They were looking to jump into the deep end and start implementing the NIST Cybersecurity Framework, which CMMC is based upon.

A New World: The Cloud and Statistical Computing

A New World: The Cloud and Statistical Computing For biotechs, statistical computing has traditionally required complex on-premises infrastructure. Configuring servers and storage for data science became cumbersome and fluctuating project needs made scaling a headache. An immediate solution was needed, especially considering the complex needs of biostatisticians and data scientists alike. Enter The Cloud Enter the cloud revolution.

September Release Rollup: DXF File Preview in the iOS App, Support for Sharing Large Files Associated with Legal Holds, Ransomware Detection Sensitivity Adjustment, and More

This month's release rollup includes product updates and enhancements from Egnyte around DXF file preview in the iOS app, support for sharing large files associated with legal holds, and ransomware detection sensitivity adjustment. Below is a summary of these and other new releases. Visit the linked articles for more details.

3 Keys to Success for Biotech IT Leaders

This year’s Egnyte Life Science Summit featured great insights from industry experts. Nate McBride's presentation, "The Calculus of IT," was well received for the useful direction it provided emerging biotechs looking to mature their IT stack and operations. Three major priority areas were identified to help position the emerging biotech for success.

Enabling Secure Collaboration for Biotechs With Egnyte - A Nimbus Therapeutics Story

In the fast-paced world of biotech, speed and agility can make or break your ability to get new therapies to market. Without its own labs, Nimbus Therapeutics relies on a global network of partners to drive development. In this session, Rebecca Carazza, Head of Information Systems at Nimbus Therapeutics, shares insights about how their biotech firm in Boston, Massachusetts, deployed Egnyte to address the unique challenges of their organization.